Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 5
1978 2
1979 2
1980 2
1981 2
1982 2
1983 3
1984 5
1985 4
1986 4
1987 3
1988 11
1989 5
1990 6
1991 8
1992 12
1993 11
1994 15
1995 17
1996 24
1997 19
1998 34
1999 42
2000 55
2001 56
2002 68
2003 65
2004 94
2005 76
2006 81
2007 90
2008 108
2009 123
2010 139
2011 130
2012 130
2013 123
2014 148
2015 161
2016 155
2017 131
2018 151
2019 163
2020 146
2021 135
2022 96
2023 95
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

2,647 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Breast cancer, susceptibility to"
Page 1
Coffee consumption and risk of breast cancer: A Mendelian randomization study.
Ellingjord-Dale M, Papadimitriou N, Katsoulis M, Yee C, Dimou N, Gill D, Aune D, Ong JS, MacGregor S, Elsworth B, Lewis SJ, Martin RM, Riboli E, Tsilidis KK. Ellingjord-Dale M, et al. PLoS One. 2021 Jan 19;16(1):e0236904. doi: 10.1371/journal.pone.0236904. eCollection 2021. PLoS One. 2021. PMID: 33465101 Free PMC article.
BACKGROUND: Observational studies have reported either null or weak protective associations for coffee consumption and risk of breast cancer. METHODS: We conducted a two-sample Mendelian randomization (MR) analysis to evaluate the relationship between coffee …
BACKGROUND: Observational studies have reported either null or weak protective associations for coffee consumption and risk of breast …
Alcohol consumption, blood DNA methylation and breast cancer: a Mendelian randomisation study.
Zhou X, Yu L, Wang L, Xiao J, Sun J, Zhou Y, Xu X, Xu W, Spiliopoulou A, Timofeeva M, Zhang X, He Y, Yang H, Campbell H, Zhang B, Zhu Y, Theodoratou E, Li X. Zhou X, et al. Eur J Epidemiol. 2022 Jul;37(7):701-712. doi: 10.1007/s10654-022-00886-1. Epub 2022 Jun 16. Eur J Epidemiol. 2022. PMID: 35708873 Free PMC article.
Alcohol intake is thought to be a risk factor for breast cancer, but the causal relationship and carcinogenic mechanisms are not clear. ...Epigenetic MR analysis identified four CpG sites, cg03260624 near CDC7 gene, cg10816169 near ZNF318 gene, cg03345232 near RIN3 …
Alcohol intake is thought to be a risk factor for breast cancer, but the causal relationship and carcinogenic mechanisms are n …
Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review.
Mokbel K, Mokbel K. Mokbel K, et al. In Vivo. 2019 Jul-Aug;33(4):983-997. doi: 10.21873/invivo.11568. In Vivo. 2019. PMID: 31280187 Free PMC article. Review.
Numerous dietary components and vitamins have been found to inhibit the molecular events and signalling pathways associated with various stages of breast cancer development. To identify the vitamins and dietary micronutrients that exert protective effects against …
Numerous dietary components and vitamins have been found to inhibit the molecular events and signalling pathways associated with various sta …
Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE, Lostumbo L, Wallace J, Ko H. Carbine NE, et al. Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4. Cochrane Database Syst Rev. 2018. PMID: 29620792 Free PMC article. Review.
OBJECTIVES: (i) To determine whether risk-reducing mastectomy reduces death rates from any cause in women who have never had breast cancer and in women who have a history of breast cancer in one breast, and (ii) to examine the effect of risk-red …
OBJECTIVES: (i) To determine whether risk-reducing mastectomy reduces death rates from any cause in women who have never had breast …
Familial leukemias.
Wiernik PH. Wiernik PH. Curr Treat Options Oncol. 2015 Feb;16(2):8. doi: 10.1007/s11864-014-0323-3. Curr Treat Options Oncol. 2015. PMID: 25762123 Review.
Genome-wide association studies have identified a number of genetic sites that appear to relate to susceptibility to leukemia in certain families and occasionally to susceptibility to a specific leukemia in general. ...Patients with CLL have approximately a 10% chan …
Genome-wide association studies have identified a number of genetic sites that appear to relate to susceptibility to leukemia in cert …
Advances in HER2 testing.
Chen Y, Liu L, Ni R, Zhou W. Chen Y, et al. Adv Clin Chem. 2019;91:123-162. doi: 10.1016/bs.acc.2019.03.004. Epub 2019 May 10. Adv Clin Chem. 2019. PMID: 31331487 Review.
HER2-positive breast cancer is a particularly aggressive type of breast cancer. ...
HER2-positive breast cancer is a particularly aggressive type of breast cancer. ...
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Roy van Zuidewijn DBW, Zonderland HM, Tollenaar RAEM, Lobbes MBI, Ausems MGEM, van 't Riet M, Hooning MJ, Mares-Engelberts I, Luiten EJT, Heijnsdijk EAM, Verhoef C, Karssemeijer N, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA; FaMRIsc study group. Saadatmand S, et al. Lancet Oncol. 2019 Aug;20(8):1136-1147. doi: 10.1016/S1470-2045(19)30275-X. Epub 2019 Jun 17. Lancet Oncol. 2019. PMID: 31221620 Clinical Trial.
Screening guidelines for women with familial risk of breast cancer differ between countries. We did a randomised controlled trial (FaMRIsc) to compare MRI screening with mammography in women with familial risk. METHODS: In this multicentre, randomis …
Screening guidelines for women with familial risk of breast cancer differ between countries. We did a randomised contro …
Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype.
Almeida CF, Teixeira N, Correia-da-Silva G, Amaral C. Almeida CF, et al. Molecules. 2021 Dec 28;27(1):156. doi: 10.3390/molecules27010156. Molecules. 2021. PMID: 35011388 Free PMC article. Review.
In fact, most of the studies regarding their effects on breast tumors have been conducted on triple-negative breast cancer (TNBC). ...This review intends to help clarify the clinical potential of cannabinoids for each breast cancer subtyp …
In fact, most of the studies regarding their effects on breast tumors have been conducted on triple-negative breast cancer …
Prophylactic mastectomy.
Newman LA, Kuerer HM, Hung KK, Vlastos G, Ames FC, Ross MI, Singletary SE. Newman LA, et al. J Am Coll Surg. 2000 Sep;191(3):322-30. doi: 10.1016/s1072-7515(00)00361-6. J Am Coll Surg. 2000. PMID: 10989906 Review.
The data are limited about the efficacy of prophylactic mastectomy in humans, but recent studies suggest that it results in up to 90% reduction in the risk for breast cancer. Total mastectomy is technically a more definitive procedure, although reported series have …
The data are limited about the efficacy of prophylactic mastectomy in humans, but recent studies suggest that it results in up to 90% reduct …
Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.
Eve L, Fervers B, Le Romancer M, Etienne-Selloum N. Eve L, et al. Int J Mol Sci. 2020 Nov 30;21(23):9139. doi: 10.3390/ijms21239139. Int J Mol Sci. 2020. PMID: 33266302 Free PMC article. Review.
Breast cancer (BC) is the second most common cancer and the fifth deadliest in the world. Exposure to endocrine disrupting pollutants has been suggested to contribute to the increase in disease incidence. Indeed, a growing number of researchershave inv …
Breast cancer (BC) is the second most common cancer and the fifth deadliest in the world. Exposure to endocrine disrupt …
2,647 results